|
Gene: ATP5F1 |
Gene summary for ATP5F1 |
Gene summary. |
Gene information | Species | Human | Gene symbol | ATP5F1 | Gene ID | 515 |
Gene name | ATP synthase peripheral stalk-membrane subunit b | |
Gene Alias | ATP5F1 | |
Cytomap | 1p13.2 | |
Gene Type | protein-coding | GO ID | GO:0006091 | UniProtAcc | P24539 |
Top |
Malignant transformation analysis |
Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
Malignant transformation involving gene list. |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
515 | ATP5F1 | GSM4909281 | Human | Breast | IDC | 3.80e-09 | -2.35e-01 | 0.21 |
515 | ATP5F1 | GSM4909282 | Human | Breast | IDC | 8.23e-09 | -2.35e-01 | -0.0288 |
515 | ATP5F1 | GSM4909285 | Human | Breast | IDC | 1.78e-08 | -2.35e-01 | 0.21 |
515 | ATP5F1 | GSM4909286 | Human | Breast | IDC | 3.80e-09 | -2.35e-01 | 0.1081 |
515 | ATP5F1 | GSM4909287 | Human | Breast | IDC | 5.28e-10 | -2.35e-01 | 0.2057 |
515 | ATP5F1 | GSM4909290 | Human | Breast | IDC | 1.13e-06 | -2.35e-01 | 0.2096 |
515 | ATP5F1 | GSM4909291 | Human | Breast | IDC | 4.38e-05 | -2.35e-01 | 0.1753 |
515 | ATP5F1 | GSM4909293 | Human | Breast | IDC | 1.75e-09 | -2.35e-01 | 0.1581 |
515 | ATP5F1 | GSM4909294 | Human | Breast | IDC | 3.80e-09 | -2.35e-01 | 0.2022 |
515 | ATP5F1 | GSM4909295 | Human | Breast | IDC | 1.25e-03 | -2.35e-01 | 0.0898 |
515 | ATP5F1 | GSM4909296 | Human | Breast | IDC | 1.78e-08 | -2.35e-01 | 0.1524 |
515 | ATP5F1 | GSM4909297 | Human | Breast | IDC | 3.52e-11 | -2.35e-01 | 0.1517 |
515 | ATP5F1 | GSM4909298 | Human | Breast | IDC | 3.80e-09 | -2.35e-01 | 0.1551 |
515 | ATP5F1 | GSM4909299 | Human | Breast | IDC | 1.75e-09 | -2.35e-01 | 0.035 |
515 | ATP5F1 | GSM4909300 | Human | Breast | IDC | 5.31e-03 | -2.35e-01 | 0.0334 |
515 | ATP5F1 | GSM4909301 | Human | Breast | IDC | 8.04e-10 | -2.35e-01 | 0.1577 |
515 | ATP5F1 | GSM4909302 | Human | Breast | IDC | 7.78e-10 | -2.35e-01 | 0.1545 |
515 | ATP5F1 | GSM4909304 | Human | Breast | IDC | 3.80e-09 | -2.35e-01 | 0.1636 |
515 | ATP5F1 | GSM4909305 | Human | Breast | IDC | 2.16e-06 | -2.35e-01 | 0.0436 |
515 | ATP5F1 | GSM4909306 | Human | Breast | IDC | 1.69e-10 | -2.35e-01 | 0.1564 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 |
Transcriptomic changes along malignancy continuum. |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
Figure of enriched GO biological processes. |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | |
Colorectum | SER | |
Colorectum | MSS | |
Colorectum | MSI-H | |
Colorectum | FAP |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
Enriched GO biological processes. |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000609111 | Stomach | CAG with IM | generation of precursor metabolites and energy | 86/1050 | 490/18723 | 1.45e-21 | 1.93e-18 | 86 |
GO:000906011 | Stomach | CAG with IM | aerobic respiration | 49/1050 | 189/18723 | 5.39e-20 | 5.75e-17 | 49 |
GO:004533311 | Stomach | CAG with IM | cellular respiration | 54/1050 | 230/18723 | 9.39e-20 | 8.34e-17 | 54 |
GO:001598011 | Stomach | CAG with IM | energy derivation by oxidation of organic compounds | 64/1050 | 318/18723 | 1.96e-19 | 1.49e-16 | 64 |
GO:001598511 | Stomach | CAG with IM | energy coupled proton transport, down electrochemical gradient | 16/1050 | 26/18723 | 2.67e-14 | 1.30e-11 | 16 |
GO:001598611 | Stomach | CAG with IM | ATP synthesis coupled proton transport | 16/1050 | 26/18723 | 2.67e-14 | 1.30e-11 | 16 |
GO:190260011 | Stomach | CAG with IM | proton transmembrane transport | 34/1050 | 157/18723 | 7.15e-12 | 2.38e-09 | 34 |
GO:000914411 | Stomach | CAG with IM | purine nucleoside triphosphate metabolic process | 25/1050 | 88/18723 | 8.00e-12 | 2.40e-09 | 25 |
GO:000920611 | Stomach | CAG with IM | purine ribonucleoside triphosphate biosynthetic process | 22/1050 | 68/18723 | 8.10e-12 | 2.40e-09 | 22 |
GO:000920511 | Stomach | CAG with IM | purine ribonucleoside triphosphate metabolic process | 24/1050 | 82/18723 | 1.03e-11 | 2.76e-09 | 24 |
GO:000914511 | Stomach | CAG with IM | purine nucleoside triphosphate biosynthetic process | 22/1050 | 69/18723 | 1.13e-11 | 2.86e-09 | 22 |
GO:000675411 | Stomach | CAG with IM | ATP biosynthetic process | 20/1050 | 57/18723 | 1.32e-11 | 3.14e-09 | 20 |
GO:004277611 | Stomach | CAG with IM | mitochondrial ATP synthesis coupled proton transport | 12/1050 | 19/18723 | 3.18e-11 | 6.78e-09 | 12 |
GO:000920111 | Stomach | CAG with IM | ribonucleoside triphosphate biosynthetic process | 22/1050 | 74/18723 | 5.34e-11 | 1.09e-08 | 22 |
GO:000919911 | Stomach | CAG with IM | ribonucleoside triphosphate metabolic process | 24/1050 | 89/18723 | 7.02e-11 | 1.34e-08 | 24 |
GO:000914211 | Stomach | CAG with IM | nucleoside triphosphate biosynthetic process | 23/1050 | 85/18723 | 1.62e-10 | 2.98e-08 | 23 |
GO:000683911 | Stomach | CAG with IM | mitochondrial transport | 42/1050 | 254/18723 | 2.58e-10 | 4.44e-08 | 42 |
GO:000914111 | Stomach | CAG with IM | nucleoside triphosphate metabolic process | 26/1050 | 112/18723 | 4.23e-10 | 6.83e-08 | 26 |
GO:000915011 | Stomach | CAG with IM | purine ribonucleotide metabolic process | 48/1050 | 368/18723 | 4.36e-08 | 3.32e-06 | 48 |
GO:000616311 | Stomach | CAG with IM | purine nucleotide metabolic process | 50/1050 | 396/18723 | 6.52e-08 | 4.63e-06 | 50 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 |
Enriched KEGG pathways. |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0501218 | Breast | Precancer | Parkinson disease | 99/684 | 266/8465 | 3.58e-42 | 5.65e-40 | 4.33e-40 | 99 |
hsa0502016 | Breast | Precancer | Prion disease | 95/684 | 273/8465 | 1.39e-37 | 1.46e-35 | 1.12e-35 | 95 |
hsa0501616 | Breast | Precancer | Huntington disease | 98/684 | 306/8465 | 2.85e-35 | 2.25e-33 | 1.72e-33 | 98 |
hsa0019016 | Breast | Precancer | Oxidative phosphorylation | 59/684 | 134/8465 | 6.15e-30 | 3.24e-28 | 2.48e-28 | 59 |
hsa0501016 | Breast | Precancer | Alzheimer disease | 103/684 | 384/8465 | 1.03e-29 | 4.66e-28 | 3.57e-28 | 103 |
hsa0501416 | Breast | Precancer | Amyotrophic lateral sclerosis | 98/684 | 364/8465 | 2.13e-28 | 8.41e-27 | 6.44e-27 | 98 |
hsa0502216 | Breast | Precancer | Pathways of neurodegeneration - multiple diseases | 112/684 | 476/8465 | 6.96e-27 | 2.44e-25 | 1.87e-25 | 112 |
hsa0520818 | Breast | Precancer | Chemical carcinogenesis - reactive oxygen species | 68/684 | 223/8465 | 3.61e-23 | 1.14e-21 | 8.73e-22 | 68 |
hsa0471418 | Breast | Precancer | Thermogenesis | 68/684 | 232/8465 | 4.40e-22 | 1.26e-20 | 9.69e-21 | 68 |
hsa0541518 | Breast | Precancer | Diabetic cardiomyopathy | 63/684 | 203/8465 | 5.63e-22 | 1.48e-20 | 1.14e-20 | 63 |
hsa0501219 | Breast | Precancer | Parkinson disease | 99/684 | 266/8465 | 3.58e-42 | 5.65e-40 | 4.33e-40 | 99 |
hsa0502017 | Breast | Precancer | Prion disease | 95/684 | 273/8465 | 1.39e-37 | 1.46e-35 | 1.12e-35 | 95 |
hsa0501617 | Breast | Precancer | Huntington disease | 98/684 | 306/8465 | 2.85e-35 | 2.25e-33 | 1.72e-33 | 98 |
hsa0019017 | Breast | Precancer | Oxidative phosphorylation | 59/684 | 134/8465 | 6.15e-30 | 3.24e-28 | 2.48e-28 | 59 |
hsa0501017 | Breast | Precancer | Alzheimer disease | 103/684 | 384/8465 | 1.03e-29 | 4.66e-28 | 3.57e-28 | 103 |
hsa0501417 | Breast | Precancer | Amyotrophic lateral sclerosis | 98/684 | 364/8465 | 2.13e-28 | 8.41e-27 | 6.44e-27 | 98 |
hsa0502217 | Breast | Precancer | Pathways of neurodegeneration - multiple diseases | 112/684 | 476/8465 | 6.96e-27 | 2.44e-25 | 1.87e-25 | 112 |
hsa0520819 | Breast | Precancer | Chemical carcinogenesis - reactive oxygen species | 68/684 | 223/8465 | 3.61e-23 | 1.14e-21 | 8.73e-22 | 68 |
hsa0471419 | Breast | Precancer | Thermogenesis | 68/684 | 232/8465 | 4.40e-22 | 1.26e-20 | 9.69e-21 | 68 |
hsa0541519 | Breast | Precancer | Diabetic cardiomyopathy | 63/684 | 203/8465 | 5.63e-22 | 1.48e-20 | 1.14e-20 | 63 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 |
Top |
Cell-cell communication analysis |
Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
Annotation of somatic variants for genes involved in malignant transformation |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ATP5F1 | SNV | Missense_Mutation | c.155N>T | p.Gly52Val | p.G52V | P24539 | protein_coding | deleterious(0) | probably_damaging(0.992) | TCGA-A8-A06X-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
ATP5F1 | SNV | Missense_Mutation | c.482N>G | p.Gln161Arg | p.Q161R | P24539 | protein_coding | deleterious(0) | benign(0.184) | TCGA-AO-A03T-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cyclophosphamide | SD | |
ATP5F1 | insertion | Frame_Shift_Ins | novel | c.116_117insCCTGATGACAAAGAACAGTACCTGTGTGGGGAGA | p.His40LeufsTer21 | p.H40Lfs*21 | P24539 | protein_coding | TCGA-BH-A0B8-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | arimidex | SD | ||
ATP5F1 | SNV | Missense_Mutation | novel | c.109G>T | p.Gly37Trp | p.G37W | P24539 | protein_coding | deleterious(0.01) | possibly_damaging(0.604) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
ATP5F1 | SNV | Missense_Mutation | c.373N>A | p.Asp125Asn | p.D125N | P24539 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-C5-A1BQ-01 | Cervix | cervical & endocervical cancer | Female | >=65 | III/IV | Chemotherapy | cisplatin | CR | |
ATP5F1 | SNV | Missense_Mutation | c.618G>A | p.Met206Ile | p.M206I | P24539 | protein_coding | tolerated(0.41) | benign(0.049) | TCGA-DS-A0VL-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
ATP5F1 | SNV | Missense_Mutation | novel | c.385N>A | p.Glu129Lys | p.E129K | P24539 | protein_coding | deleterious(0.01) | benign(0.171) | TCGA-HM-A4S6-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Chemotherapy | cisplatin | CR |
ATP5F1 | SNV | Missense_Mutation | rs770948319 | c.406G>A | p.Glu136Lys | p.E136K | P24539 | protein_coding | tolerated(0.52) | possibly_damaging(0.564) | TCGA-MU-A51Y-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
ATP5F1 | SNV | Missense_Mutation | c.582G>T | p.Lys194Asn | p.K194N | P24539 | protein_coding | deleterious(0.02) | probably_damaging(0.989) | TCGA-AA-3977-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
ATP5F1 | SNV | Missense_Mutation | c.189N>A | p.Phe63Leu | p.F63L | P24539 | protein_coding | tolerated(0.24) | benign(0.027) | TCGA-CA-6718-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | PD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
Identification of chemicals and drugs interact with genes involved in malignant transfromation |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |